Beneficial effects of maprotiline on irritative urinary symptoms in multiple sclerosis.
D000328:Adult; D000873:Anthracenes / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000627:therapeutic use*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications*; D011446:Prospective Studies; D014555:Urination Disorders / Q000188:drug therapy* / Q000209:etiology
D000873:Anthracenes; D008376:Maprotiline